Lex ano - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 25,185,761 | 26,515,227 | 33,743,106 | 34,193,128 | 35,003,931 | 41,123,207 | 45,821,835 | 45,038,474 |
| Profit before tax | 2,124,088 | 1,623,266 | 2,112,847 | 2,213,602 | 1,741,787 | 2,348,606 | 2,582,236 | 901,684 |
| Net profit | 2,037,996 | 1,559,188 | 2,026,872 | 2,124,232 | 1,667,295 | 2,253,557 | 2,470,443 | 851,800 |
| Equity | 4,555,481 | 2,365,213 | 4,392,085 | 5,516,317 | 6,007,141 | 7,390,108 | 8,331,139 | 7,418,233 |
| Liabilities | 668,907 | 960,604 | 574,955 | 1,304,912 | 545,990 | 2,080,096 | 824,872 | 2,407,955 |
| Non-current assets | 41,269 | 38,345 | 21,905 | 36,348 | 31,515 | 29,817 | 197,268 | 319,723 |
| Current assets | 5,167,020 | 3,266,806 | 4,924,469 | 6,764,211 | 6,554,350 | 9,373,939 | 8,878,496 | 9,478,643 |
| Total assets | 5,208,289 | 3,305,151 | 4,946,374 | 6,800,559 | 6,585,865 | 9,403,756 | 9,075,764 | 9,798,366 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 212,223 | 347,158 | 541,815 |
| Social insurance contributions | - | - | - | - | - | 374,586 | 419,373 | 560,578 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +42.1% | +5.3% | +27.3% | +1.3% | +2.4% | +17.5% | +11.4% | -1.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 39.1% | 47.2% | 41.0% | 31.2% | 25.3% | 24.0% | 27.2% | 8.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 44.7% | 65.9% | 46.1% | 38.5% | 27.8% | 30.5% | 29.7% | 11.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.1% | 5.9% | 6.0% | 6.2% | 4.8% | 5.5% | 5.4% | 1.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 8.4% | 6.1% | 6.3% | 6.5% | 5.0% | 5.7% | 5.6% | 2.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.4 | 0.1 | 0.2 | 0.1 | 0.3 | 0.1 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,149,158 | 1,074,940 | 1,253,612 | 1,250,970 | 1,183,233 | 1,142,311 | 1,136,079 | 1,017,819 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Lex ano - Social security debts
The company had no debts to Sodra
Lex ano - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-18 | 2025-06-18 | 113590.65 |
| 2025-06-17 | 2025-06-17 | 113560.25 |
| 2025-06-14 | 2025-06-16 | 112587.45 |
| 2025-04-04 | 2025-04-04 | 951.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Lex ano, UAB (code 300153209) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €45.04M and net profit of €851.8K, with a profit margin of 1.9%. Revenue declined by 1.7% year on year, although it remained 9.5% above the 2023 level. Profitability weakened more sharply in 2025 after net profit of €2.25M in 2023 and €2.47M in 2024, indicating a notable compression of margins in the latest year. The balance sheet remained solid, with total assets of €9.80M, equity of €7.42M and liabilities of €2.41M at year-end 2025. The equity ratio stood at 75.7%, debt-to-equity at 0.32, and asset turnover at 4.60x. Operational productivity was also strong, with revenue per employee of €1.02M and profit per employee of €19.4K. Overall, the company shows high turnover and a strong capital base, but lower earnings intensity in 2025 compared with the prior two years.